Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation-Reference-Cited by-同舟云学术

Novel transferrin modified and doxorubicin loaded Pluronic 85/lipid-polymeric nanoparticles for the treatment of leukemia: In vitro and in vivo therapeutic effect evaluation

Published:2017-02 Issue: Volume:86 Page:547-554
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhu Baomin,Zhang Huanying,Yu Lianling

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference48 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J. Clin.,2012

2. Role of integrated cancer nanomedicine in overcoming drug resistance;Iyer;Adv. Drug Deliv. Rev.,2013

3. Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia;Ma;J Biomed. Nanotechnol.,2009

4. Anticancer therapy induced cardiotoxicity: review of the literature;Geiger;Anticancer Drugs,2010

5. Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment;Morotti;Expert Opin. Drug Metab. Toxicol.,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toward the scale-up production of polymeric nanotherapeutics for cancer clinical trials;Nano Today;2024-06

2. Sustained Release of Doxorubicin through Semi-Interpenetrating Polymer Network-Stabilized Micelles;Macromolecular Research;2023-08-22

3. Binary Nanodrug-Delivery System Designed for Leukemia Therapy: Aptamer- and Transferrin-Codecorated Daunorubicin- and Luteolin-Coloaded Nanoparticles;Drug Design, Development and Therapy;2023-01

4. Nanoparticles targeting hematopoietic stem and progenitor cells: Multimodal carriers for the treatment of hematological diseases;Frontiers in Genome Editing;2022-11-02

5. Nanoprecipitation technology to prepare carrier systems of interest in pharmaceutics: An overview of patenting;International Journal of Pharmaceutics;2022-02